DRD3 and drug-induced dyskinesia: Carriers of dopamine receptors DRD2 haplotypes and possibly the BDNF variants rs6265 and DRD3 haplotypes, were at increased risk of dyskinesia, suggesting that these genes may be involved in dyskinesia-related pathomechanisms.